271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05527444 (ClinicalTrials.gov)	March 15, 2022	6/5/2022	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	Ankylosing Spondylitis	Drug: Secukinumab 150 mg/ml;Drug: Adalimumab Ab;Drug: NSAID;Drug: Thalidomide Pill	Qilu Hospital of Shandong University	NULL	Recruiting	18 Years	65 Years	All	100	Phase 4	China
2	ChiCTR-TRC-13003449	2013-04-25	2013-06-07	A multicenter, randomized, double-blind, placebo-controlled, Phase II clinical study of Thalidomidei ...	A multicenter, randomized, double-blind, placebo-controlled, Phase II clinical study of Thalidomidei ...	Ankylosing Spondylitis	Thalidomide150mg:Thalidomide25mg/qd.po.2weeks; 50mg/qd.po.2weeks;100mg/qd.po.2weeks; 150mg/qd, po., ...	The General Hospital of People's Liberation Army	NULL	Completed	18	65	Both	Thalidomide 150mg:80;Thalidomide 100mg:80;Control group:40;	2 (Phase 2 study)	China
3	NCT02201043 (ClinicalTrials.gov)	February 2013	23/7/2014	Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis	A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Study of Thalidomidei ...	Ankylosing Spondylitis	Drug: Thalidomide 150mg;Drug: Thalidomide 100mg;Drug: Placebo	Shanghai Pharmaceuticals Holding Co., Ltd	NULL	Completed	18 Years	65 Years	Both	197	Phase 2	China
4	ChiCTR-ONRC-10000858	2010-05-10	2010-04-28	Research on safety tolerance and pharmacokinetics of oral muti-dose Thalidomide	Research on safety tolerance and pharmacokinetics of oral muti-dose Thalidomide	Ankylosing Spondylitis	Group A:Muti-dose Thalidomide;GroupB:Muti-dose Thalidomideand Diclofenacsodium enteric-coated tablet ...	Chinese PLA General Hospital	NULL	Completed	18	45	Both	Group A:15;GroupB:12;	I (Phase 1 study)	China

First Previous1Next Last